Most viewed this week from JAMA Oncology: Glucagon-like peptide-1 receptor agonists (#GLP1s) are associated with a reduced overall #cancer risk in adults with #obesity, lowering the risk for endometrial, ovarian, and meningioma cancers
Improved Metabolic Health Tirzepatide users also enjoy improved health markers, including better blood sugar control, reduced blood pressure, and healthier cholesterol levels, all of which contribute to reduced inflammation and enhanced overall wellbeing
Patients who have used Melanotan and notice changing moles should have their moles evaluated
Our El Paso clinic is ready to support your path to a healthier future
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes